NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy

Combretastatin A-4 (CA-4), a tubulin-depolymerizing agent, shows promising antitumor efficacy and has been under several clinical trials in solid tumors for 10 years. Autophagy has an important pro-survival role in cancer therapy, thus targeting autophagy may improve the efficacy of antitumor agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongsheng, Li, Wen, Xu, Jing, Zhang, Tao, Zuo, Dongqing, Zhou, Zifei, Lin, Binhui, Wang, Gangyang, Wang, Zhuoying, Sun, Wei, Sun, Mengxiong, Chang, Shimin, Cai, Zhengdong, Hua, Yingqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636982/
https://www.ncbi.nlm.nih.gov/pubmed/28906492
http://dx.doi.org/10.1038/cddis.2017.438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636982/
https://www.ncbi.nlm.nih.gov/pubmed/28906492
http://dx.doi.org/10.1038/cddis.2017.438

Ejemplares similares